Amanote Research
Register
Sign In
Discovery of Potent 2Aryl-6,7-Dihydro5Hpyrrolo[1,2a]imidazoles as WDR5-WIN-Site Inhibitors Using Fragment-Based Methods and Structure-Based Design
doi 10.1021/acs.jmedchem.8b00375.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Fragment-Based Discovery of Potent and Selective DDR1/2 Inhibitors
ACS Medicinal Chemistry Letters
Organic Chemistry
Biochemistry
Drug Discovery
Fragment-Based Discovery of Potent and Selective DDR1/2 Inhibitors
Structure-Based Design of Potent and Selective CK1γ Inhibitors
ACS Medicinal Chemistry Letters
Organic Chemistry
Biochemistry
Drug Discovery
Discovery of Conformationally Restricted Human Glutaminyl Cyclase Inhibitors as Potent Anti-Alzheimers Agents by Structure-Based Design
Fragment-Based and Structure-Guided Discovery and Optimization of Rho Kinase Inhibitors
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
Discovery of Novel KRAS-PDE Inhibitors by Fragment-Based Drug Design
Fragment-Based Discovery of 6Arylindazole JAK Inhibitors
Discovery of 2Indole-Acylsulfonamide Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods
Discovery of 2Indole-Acylsulfonamide Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods
